Valsartan API Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Valsartan API study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Valsartan API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Valsartan API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Valsartan API companies in 2021 (%)
The global Valsartan API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity Above 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Valsartan API include Biophore India Pharmaceuticals, Zydus Lifesciences, Harman Finochem, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Macleods Pharmaceuticals, MSN Life Sciences, Mylan Laboratories and Dr. Reddy's Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Valsartan API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Valsartan API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Valsartan API Market Segment Percentages, by Type, 2021 (%)
Purity Above 99%
Purity Below 99%
Global Valsartan API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Valsartan API Market Segment Percentages, by Application, 2021 (%)
Tablet
Capsule
Global Valsartan API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Valsartan API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Valsartan API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Valsartan API revenues share in global market, 2021 (%)
Key companies Valsartan API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Valsartan API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biophore India Pharmaceuticals
Zydus Lifesciences
Harman Finochem
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Macleods Pharmaceuticals
MSN Life Sciences
Mylan Laboratories
Dr. Reddy's Laboratories
Ipca Laboratories
Divis Laboratories
Novartis
Lupin Ltd
Jubilant Generics
Alembic Pharmaceuticals
Aurobindo Pharma
Chromo Laboratories India
Hetero Labs Ltd
Krka
Zhejiang Tianyu Pharmaceutical
Zhejiang Second Pharma
Zhuhai Rundu Pharmaceutical
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Valsartan API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Valsartan API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Valsartan API Overall Market Size
2.1 Global Valsartan API Market Size: 2021 VS 2028
2.2 Global Valsartan API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Valsartan API Sales: 2017-2028
3 Company Landscape
3.1 Top Valsartan API Players in Global Market
3.2 Top Global Valsartan API Companies Ranked by Revenue
3.3 Global Valsartan API Revenue by Companies
3.4 Global Valsartan API Sales by Companies
3.5 Global Valsartan API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Valsartan API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Valsartan API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Valsartan API Players in Global Market
3.8.1 List of Global Tier 1 Valsartan API Companies
3.8.2 List of Global Tier 2 and Tier 3 Valsartan API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Valsartan API Market Size Markets, 2021 & 2028
4.1.2 Purity Above 99%
4.1.3 Purity Below 99%
4.2 By Type - Global Valsartan API Revenue & Forecasts
4.2.1 By Type - Global Valsartan API Revenue, 2017-2022
4.2.2 By Type - Global Valsartan API Revenue, 2023-2028
4.2.3 By Type - Global Valsartan API Revenue Market Share, 2017-2028
4.3 By Type - Global Valsartan API Sales & Forecasts
4.3.1 By Type - Global Valsartan API Sales, 2017-2022
4.3.2 By Type - Global Valsartan API Sales, 2023-2028
4.3.3 By Type - Global Valsartan API Sales Market Share, 2017-2028
4.4 By Type - Global Valsartan API Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Valsartan API Market Size, 2021 & 2028
5.1.2 Tablet
5.1.3 Capsule
5.2 By Application - Global Valsartan API Revenue & Forecasts
5.2.1 By Application - Global Valsartan API Revenue, 2017-2022
5.2.2 By Application - Global Valsartan API Revenue, 2023-2028
5.2.3 By Application - Global Valsartan API Revenue Market Share, 2017-2028
5.3 By Application - Global Valsartan API Sales & Forecasts
5.3.1 By Application - Global Valsartan API Sales, 2017-2022
5.3.2 By Application - Global Valsartan API Sales, 2023-2028
5.3.3 By Application - Global Valsartan API Sales Market Share, 2017-2028
5.4 By Application - Global Valsartan API Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Valsartan API Market Size, 2021 & 2028
6.2 By Region - Global Valsartan API Revenue & Forecasts
6.2.1 By Region - Global Valsartan API Revenue, 2017-2022
6.2.2 By Region - Global Valsartan API Revenue, 2023-2028
6.2.3 By Region - Global Valsartan API Revenue Market Share, 2017-2028
6.3 By Region - Global Valsartan API Sales & Forecasts
6.3.1 By Region - Global Valsartan API Sales, 2017-2022
6.3.2 By Region - Global Valsartan API Sales, 2023-2028
6.3.3 By Region - Global Valsartan API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Valsartan API Revenue, 2017-2028
6.4.2 By Country - North America Valsartan API Sales, 2017-2028
6.4.3 US Valsartan API Market Size, 2017-2028
6.4.4 Canada Valsartan API Market Size, 2017-2028
6.4.5 Mexico Valsartan API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Valsartan API Revenue, 2017-2028
6.5.2 By Country - Europe Valsartan API Sales, 2017-2028
6.5.3 Germany Valsartan API Market Size, 2017-2028
6.5.4 France Valsartan API Market Size, 2017-2028
6.5.5 U.K. Valsartan API Market Size, 2017-2028
6.5.6 Italy Valsartan API Market Size, 2017-2028
6.5.7 Russia Valsartan API Market Size, 2017-2028
6.5.8 Nordic Countries Valsartan API Market Size, 2017-2028
6.5.9 Benelux Valsartan API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Valsartan API Revenue, 2017-2028
6.6.2 By Region - Asia Valsartan API Sales, 2017-2028
6.6.3 China Valsartan API Market Size, 2017-2028
6.6.4 Japan Valsartan API Market Size, 2017-2028
6.6.5 South Korea Valsartan API Market Size, 2017-2028
6.6.6 Southeast Asia Valsartan API Market Size, 2017-2028
6.6.7 India Valsartan API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Valsartan API Revenue, 2017-2028
6.7.2 By Country - South America Valsartan API Sales, 2017-2028
6.7.3 Brazil Valsartan API Market Size, 2017-2028
6.7.4 Argentina Valsartan API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Valsartan API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Valsartan API Sales, 2017-2028
6.8.3 Turkey Valsartan API Market Size, 2017-2028
6.8.4 Israel Valsartan API Market Size, 2017-2028
6.8.5 Saudi Arabia Valsartan API Market Size, 2017-2028
6.8.6 UAE Valsartan API Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Biophore India Pharmaceuticals
7.1.1 Biophore India Pharmaceuticals Corporate Summary
7.1.2 Biophore India Pharmaceuticals Business Overview
7.1.3 Biophore India Pharmaceuticals Valsartan API Major Product Offerings
7.1.4 Biophore India Pharmaceuticals Valsartan API Sales and Revenue in Global (2017-2022)
7.1.5 Biophore India Pharmaceuticals Key News
7.2 Zydus Lifesciences
7.2.1 Zydus Lifesciences Corporate Summary
7.2.2 Zydus Lifesciences Business Overview
7.2.3 Zydus Lifesciences Valsartan API Major Product Offerings
7.2.4 Zydus Lifesciences Valsartan API Sales and Revenue in Global (2017-2022)
7.2.5 Zydus Lifesciences Key News
7.3 Harman Finochem
7.3.1 Harman Finochem Corporate Summary
7.3.2 Harman Finochem Business Overview
7.3.3 Harman Finochem Valsartan API Major Product Offerings
7.3.4 Harman Finochem Valsartan API Sales and Revenue in Global (2017-2022)
7.3.5 Harman Finochem Key News
7.4 Sun Pharmaceutical Industries
7.4.1 Sun Pharmaceutical Industries Corporate Summary
7.4.2 Sun Pharmaceutical Industries Business Overview
7.4.3 Sun Pharmaceutical Industries Valsartan API Major Product Offerings
7.4.4 Sun Pharmaceutical Industries Valsartan API Sales and Revenue in Global (2017-2022)
7.4.5 Sun Pharmaceutical Industries Key News
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Corporate Summary
7.5.2 Teva Pharmaceutical Industries Business Overview
7.5.3 Teva Pharmaceutical Industries Valsartan API Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Valsartan API Sales and Revenue in Global (2017-2022)
7.5.5 Teva Pharmaceutical Industries Key News
7.6 Macleods Pharmaceuticals
7.6.1 Macleods Pharmaceuticals Corporate Summary
7.6.2 Macleods Pharmaceuticals Business Overview
7.6.3 Macleods Pharmaceuticals Valsartan API Major Product Offerings
7.6.4 Macleods Pharmaceuticals Valsartan API Sales and Revenue in Global (2017-2022)
7.6.5 Macleods Pharmaceuticals Key News
7.7 MSN Life Sciences
7.7.1 MSN Life Sciences Corporate Summary
7.7.2 MSN Life Sciences Business Overview
7.7.3 MSN Life Sciences Valsartan API Major Product Offerings
7.7.4 MSN Life Sciences Valsartan API Sales and Revenue in Global (2017-2022)
7.7.5 MSN Life Sciences Key News
7.8 Mylan Laboratories
7.8.1 Mylan Laboratories Corporate Summary
7.8.2 Mylan Laboratories Business Overview
7.8.3 Mylan Laboratories Valsartan API Major Product Offerings
7.8.4 Mylan Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.8.5 Mylan Laboratories Key News
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Corporate Summary
7.9.2 Dr. Reddy's Laboratories Business Overview
7.9.3 Dr. Reddy's Laboratories Valsartan API Major Product Offerings
7.9.4 Dr. Reddy's Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.9.5 Dr. Reddy's Laboratories Key News
7.10 Ipca Laboratories
7.10.1 Ipca Laboratories Corporate Summary
7.10.2 Ipca Laboratories Business Overview
7.10.3 Ipca Laboratories Valsartan API Major Product Offerings
7.10.4 Ipca Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.10.5 Ipca Laboratories Key News
7.11 Divis Laboratories
7.11.1 Divis Laboratories Corporate Summary
7.11.2 Divis Laboratories Valsartan API Business Overview
7.11.3 Divis Laboratories Valsartan API Major Product Offerings
7.11.4 Divis Laboratories Valsartan API Sales and Revenue in Global (2017-2022)
7.11.5 Divis Laboratories Key News
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Valsartan API Business Overview
7.12.3 Novartis Valsartan API Major Product Offerings
7.12.4 Novartis Valsartan API Sales and Revenue in Global (2017-2022)
7.12.5 Novartis Key News
7.13 Lupin Ltd
7.13.1 Lupin Ltd Corporate Summary
7.13.2 Lupin Ltd Valsartan API Business Overview
7.13.3 Lupin Ltd Valsartan API Major Product Offerings
7.13.4 Lupin Ltd Valsartan API Sales and Revenue in Global (2017-2022)
7.13.5 Lupin Ltd Key News
7.14 Jubilant Generics
7.14.1 Jubilant Generics Corporate Summary
7.14.2 Jubilant Generics Business Overview
7.14.3 Jubilant Generics Valsartan API Major Product Offerings
7.14.4 Jubilant Generics Valsartan API Sales and Revenue in Global (2017-2022)
7.14.5 Jubilant Generics Key News
7.15 Alembic Pharmaceuticals
7.15.1 Alembic Pharmaceuticals Corporate Summary
7.15.2 Alembic Pharmaceuticals Business Overview
7.15.3 Alembic Pharmaceuticals Valsartan API Major Product Offerings
7.15.4 Alembic Pharmaceuticals Valsartan API Sales and Revenue in Global (2017-2022)
7.15.5 Alembic Pharmaceuticals Key News
7.16 Aurobindo Pharma
7.16.1 Aurobindo Pharma Corporate Summary
7.16.2 Aurobindo Pharma Business Overview
7.16.3 Aurobindo Pharma Valsartan API Major Product Offerings
7.16.4 Aurobindo Pharma Valsartan API Sales and Revenue in Global (2017-2022)
7.16.5 Aurobindo Pharma Key News
7.17 Chromo Laboratories India
7.17.1 Chromo Laboratories India Corporate Summary
7.17.2 Chromo Laboratories India Business Overview
7.17.3 Chromo Laboratories India Valsartan API Major Product Offerings
7.17.4 Chromo Laboratories India Valsartan API Sales and Revenue in Global (2017-2022)
7.17.5 Chromo Laboratories India Key News
7.18 Hetero Labs Ltd
7.18.1 Hetero Labs Ltd Corporate Summary
7.18.2 Hetero Labs Ltd Business Overview
7.18.3 Hetero Labs Ltd Valsartan API Major Product Offerings
7.18.4 Hetero Labs Ltd Valsartan API Sales and Revenue in Global (2017-2022)
7.18.5 Hetero Labs Ltd Key News
7.19 Krka
7.19.1 Krka Corporate Summary
7.19.2 Krka Business Overview
7.19.3 Krka Valsartan API Major Product Offerings
7.19.4 Krka Valsartan API Sales and Revenue in Global (2017-2022)
7.19.5 Krka Key News
7.20 Zhejiang Tianyu Pharmaceutical
7.20.1 Zhejiang Tianyu Pharmaceutical Corporate Summary
7.20.2 Zhejiang Tianyu Pharmaceutical Business Overview
7.20.3 Zhejiang Tianyu Pharmaceutical Valsartan API Major Product Offerings
7.20.4 Zhejiang Tianyu Pharmaceutical Valsartan API Sales and Revenue in Global (2017-2022)
7.20.5 Zhejiang Tianyu Pharmaceutical Key News
7.21 Zhejiang Second Pharma
7.21.1 Zhejiang Second Pharma Corporate Summary
7.21.2 Zhejiang Second Pharma Business Overview
7.21.3 Zhejiang Second Pharma Valsartan API Major Product Offerings
7.21.4 Zhejiang Second Pharma Valsartan API Sales and Revenue in Global (2017-2022)
7.21.5 Zhejiang Second Pharma Key News
7.22 Zhuhai Rundu Pharmaceutical
7.22.1 Zhuhai Rundu Pharmaceutical Corporate Summary
7.22.2 Zhuhai Rundu Pharmaceutical Business Overview
7.22.3 Zhuhai Rundu Pharmaceutical Valsartan API Major Product Offerings
7.22.4 Zhuhai Rundu Pharmaceutical Valsartan API Sales and Revenue in Global (2017-2022)
7.22.5 Zhuhai Rundu Pharmaceutical Key News
8 Global Valsartan API Production Capacity, Analysis
8.1 Global Valsartan API Production Capacity, 2017-2028
8.2 Valsartan API Production Capacity of Key Manufacturers in Global Market
8.3 Global Valsartan API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Valsartan API Supply Chain Analysis
10.1 Valsartan API Industry Value Chain
10.2 Valsartan API Upstream Market
10.3 Valsartan API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Valsartan API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Valsartan API Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|